We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+11.98%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.51B
AUM Growth
+$79.8M
(+5.6%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
27.14%
Holding
456
New
26
Increased
163
Reduced
145
Closed
50
Top Buys
| 1 |
United Therapeutics
UTHR
|
+$17.1M |
| 2 |
Take-Two Interactive
TTWO
|
+$15.5M |
| 3 |
Las Vegas Sands
LVS
|
+$12.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$12.1M |
Top Sells
| 1 |
Electronic Arts
EA
|
+$18.8M |
| 2 |
Becton Dickinson
BDX
|
+$18.6M |
| 3 |
Franco-Nevada
FNV
|
+$13.2M |
| 4 |
Biogen
BIIB
|
+$11.5M |
| 5 |
Eversource Energy
ES
|
+$10.7M |
Sector Composition
| 1 | Healthcare | 33.57% |
| 2 | Consumer Staples | 28.33% |
| 3 | Technology | 7.15% |
| 4 | Communication Services | 6.29% |
| 5 | Materials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Axos Financial
AX
$5.66B
| $15K | ﹤0.01% |
399
+261
| +189% | +$9.95K |
|
|
CMA
402
DELISTED
Comerica
CMA
| $15K | ﹤0.01% |
231
-657
| -74% | -$45.5K |
|
403
NVIDIA
NVDA
$4.91T
| $14K | ﹤0.01% |
950
-1,940
| -67% | -$28.5K |
|
404
Marathon Digital Holdings
MARA
$4.08B
| $11K | ﹤0.01% |
3,291
+1,110
| +51% | +$9.32K |
|
405
Microchip Technology
MCHP
$44B
| $3K | ﹤0.01% |
42
-1
| -2% | -$69 |
|
406
Advanced Micro Devices
AMD
$807B
| $2K | ﹤0.01% |
31
+7
| +29% | +$462 |
|
407
Adobe
ADBE
$94.3B
| – | – |
-103
| Closed | -$28K |
|
408
Arthur J. Gallagher & Co
AJG
$65.2B
| – | – |
-172
| Closed | -$29K |
|
409
Align Technology
ALGN
$12.7B
| – | – |
-238
| Closed | -$49K |
|
410
A.O. Smith
AOS
$8.11B
| – | – |
-391
| Closed | -$19K |
|
411
Amphenol
APH
$186B
| – | – |
-1,176
| Closed | -$39K |
|
412
Atmos Energy
ATO
$29.7B
| – | – |
-1,091
| Closed | -$111K |
|
413
Broadcom
AVGO
$1.76T
| – | – |
-720
| Closed | -$32K |
|
414
Bausch Health
BHC
$1.8B
| – | – |
-336,774
| Closed | -$2.34M |
|
415
Ciena
CIEN
$53B
| – | – |
-993
| Closed | -$40K |
|
416
CMS Energy
CMS
$22.8B
| – | – |
-19,207
| Closed | -$1.12M |
|
417
CenterPoint Energy
CNP
$28.2B
| – | – |
-3,302
| Closed | -$93K |
|
418
Canadian Pacific Kansas City
CP
$83.2B
| – | – |
-3,963
| Closed | -$266K |
|
|
419
Electronic Arts
EA
$52.4B
| – | – |
-162,561
| Closed | -$18.8M |
|
420
Edison International
EIX
$29.9B
| – | – |
-43,861
| Closed | -$2.48M |
|
421
Emerson Electric
EMR
$78.2B
| – | – |
-1,684
| Closed | -$123K |
|
422
F5
FFIV
$23.1B
| – | – |
-208
| Closed | -$30K |
|
423
GE Aerospace
GE
$364B
| – | – |
-5,937
| Closed | -$229K |
|
424
Graco
GGG
$12.4B
| – | – |
-545
| Closed | -$33K |
|
425
Intuitive Surgical
ISRG
$122B
| – | – |
-140
| Closed | -$26K |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q4 2022 Portfolio in Review
As of Q4 2022, TOBAM held 456 positions worth $1.51B, up 5.6% from $1.43B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TOBAM withdrew a net $58.7M in Q4 2022, closing 50 positions and reducing 145 holdings. Its most notable exit was Electronic Arts, an estimated $18.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, TOBAM opened a new position in Enerplus Corporation worth $654K.
- TOBAM's largest Q4 2022 buy was Enerplus Corporation: 36,977 shares worth $654K.
- TOBAM added most to United Therapeutics in Q4 2022, an estimated $17.1M increase.
- TOBAM's biggest Q4 2022 reduction was Becton Dickinson, cutting an estimated $18.6M.
- TOBAM fully exited Electronic Arts in Q4 2022, selling an estimated $18.8M.
- TOBAM's ten largest holdings make up 27% of its $1.51B portfolio in Q4 2022.
- TOBAM opened 26 new positions and closed 50 in Q4 2022.
- TOBAM's portfolio value rose 5.6% quarter-over-quarter to $1.51B.
Based on TOBAM's 13F filing for Q4 2022, filed 2 Feb 2023.